A Randomised, Single-dose, 3-way Crossover Study to Evaluate the Relative Bioavailability of the IX-01 Capsule Formulation Compared With the IX-01 Aqueous Dispersion Formulation, and the Effect of Food on the IX-01 Capsule Formulation, in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 25 Jul 2014
Price : $35 *
At a glance
- Drugs IX 01 (Primary)
- Indications Premature ejaculation
- Focus Pharmacokinetics
- Sponsors Ixchelsis
- 27 Jun 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 16 Jun 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 19 May 2014 New trial record